Abstract
Purpose: Surface active phospholipids (SAPLs) including dipalmitoylphosphatidylcholine (DPPC) play a vital role in the natural boundary lubricant of articular cartilage and are degraded during progression of osteoarthritis (OA). MM-II is a suspension of large multilamellar neutral liposomes composed of two phospholipids, dimyristoylphosphatidylcholine (DMPC) and DPPC which is administered via intra-articular (IA) administration and is currently in a phase 2b clinical study. In a series of ex-vivo cartilage-on-cartilage friction and wear tests, MM-II liposomes were shown to lubricate cartilage and reduce hence friction and wear.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
